Neuroendocrine control of growth hormone secretion

Combined autoradiographic and immunohistochemical evidence for an association of somatostatin binding sites with growth hormone-releasing factor-containing nerve cell bodies in the rat arcuate nucleus.

Journal of neuroendocrinology·2009

Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load.

Brain research·2002

Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity.

Endocrinology·2001

mRNA expression of the IGF system in the kidney of the hypersomatotropic rat.

Nephron·2001

Homologous upregulation of sst2 somatostatin receptor expression in the rat arcuate nucleus in vivo.

Neuroendocrinology·2001

Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.

Endocrine·2001

Gonadotrophin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty.

Acta paediatrica Scandinavica. Supplement·1991

Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics.

Acta paediatrica Scandinavica. Supplement·1991

The nature of nutritional deficiency in relation to growth failure and poverty.

Acta paediatrica Scandinavica. Supplement·1991

Aspects of anthropometric evaluation of malnutrition in childhood.

Acta paediatrica Scandinavica. Supplement·1991

Breast feeding and the older infant.

Acta paediatrica Scandinavica. Supplement·1991

Can maternal dietary supplements help in preventing infant malnutrition?

Acta paediatrica Scandinavica. Supplement·1991

Integrating transposable elements into blood gene regulatory networks reveals connectivity loss for schizophrenia genes.

The Journal of clinical investigation·2026

T-rex: standardized analysis of germline variants in whole-exome sequencing trios.

Scientific reports·2026

STX1B variant-specific synaptic dysfunction is associated with network hyperexcitability in human iPSC-derived neurons.

EBioMedicine·2026

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.

Pharmacology & therapeutics·2026

[Autism - Phenotypic variability].

Medicina·2026

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

Neurogenetics·2026

Related Experiment Videos

Neuroendocrine control of growth hormone secretion

Related Concept Videos

Combined autoradiographic and immunohistochemical evidence for an association of somatostatin binding sites with growth hormone-releasing factor-containing nerve cell bodies in the rat arcuate nucleus.

Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load.

Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity.

mRNA expression of the IGF system in the kidney of the hypersomatotropic rat.

Homologous upregulation of sst2 somatostatin receptor expression in the rat arcuate nucleus in vivo.

Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.

Gonadotrophin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty.

Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics.

The nature of nutritional deficiency in relation to growth failure and poverty.

Aspects of anthropometric evaluation of malnutrition in childhood.

Breast feeding and the older infant.

Can maternal dietary supplements help in preventing infant malnutrition?

Integrating transposable elements into blood gene regulatory networks reveals connectivity loss for schizophrenia genes.

T-rex: standardized analysis of germline variants in whole-exome sequencing trios.

STX1B variant-specific synaptic dysfunction is associated with network hyperexcitability in human iPSC-derived neurons.

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.

[Autism - Phenotypic variability].

Significant differences in phenotype and age of onset in an SPG4 family caused by whole SPAST deletion combined with a hemizygous S44L modifier.

Related Experiment Videos

Neuroendocrine control of growth hormone secretion

Related Concept Videos

Related Articles